Eversource-Wealth-Advisors

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
4,128
Total Value
1630861225
Accession Number
0001710537-25-000003
Form Type
13F-HR
Manager Name
Eversource-Wealth-Advisors
Data Enrichment
82% identified
3,393 identified735 unidentified

Holdings

4,128 positions • $1.6B total value
Manager:
Search and click to pin securities to the top
Page 177 of 201
ZIPRECRUITER, INC.
Shares:—
Value:$395
% of Portfolio:0.0% ($395/$1.6B)
FIRST ADVANTAGE CORP
Shares:—
Value:$395
% of Portfolio:0.0% ($395/$1.6B)
DIEBOLD NIXDORF, Inc
Shares:—
Value:$393
% of Portfolio:0.0% ($393/$1.6B)
BYLINE BANCORP, INC.
Shares:—
Value:$392
% of Portfolio:0.0% ($392/$1.6B)
NATIONAL STEEL CO
Shares:—
Value:$392
% of Portfolio:0.0% ($392/$1.6B)
MANNKIND CORP
Shares:—
Value:$392
% of Portfolio:0.0% ($392/$1.6B)
CARRIAGE SERVICES INC
Shares:—
Value:$388
% of Portfolio:0.0% ($388/$1.6B)
Corbus Pharmaceuticals Holdings, Inc.
Shares:—
Value:$388
% of Portfolio:0.0% ($388/$1.6B)
Spyre Therapeutics, Inc.
Shares:—
Value:$387
% of Portfolio:0.0% ($387/$1.6B)
CEMEX SAB DE CV
Shares:—
Value:$387
% of Portfolio:0.0% ($387/$1.6B)
Postal Realty Trust, Inc.
Shares:—
Value:$386
% of Portfolio:0.0% ($386/$1.6B)
Larimar Therapeutics, Inc.
Shares:—
Value:$385
% of Portfolio:0.0% ($385/$1.6B)
ASTEC INDUSTRIES INC
Shares:—
Value:$379
% of Portfolio:0.0% ($379/$1.6B)
KALTURA INC
Shares:—
Value:$378
% of Portfolio:0.0% ($378/$1.6B)
Invivyd, Inc.
Shares:—
Value:$376
% of Portfolio:0.0% ($376/$1.6B)
Theravance Biopharma, Inc.
Shares:—
Value:$375
% of Portfolio:0.0% ($375/$1.6B)
PubMatic, Inc.
Shares:—
Value:$375
% of Portfolio:0.0% ($375/$1.6B)
46434V696
Shares:—
Value:$373
% of Portfolio:0.0% ($373/$1.6B)
IGM Biosciences, Inc.
Shares:—
Value:$371
% of Portfolio:0.0% ($371/$1.6B)
92333F101
Shares:—
Value:$371
% of Portfolio:0.0% ($371/$1.6B)